Wikidata

(Q63596518)

English

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis (AD) (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Canada
0 references
Germany
0 references
Japan
0 references
main subject
dermatitis
0 references
start time
22 October 2018
0 references
end time
May 2020
0 references
number of participants
250
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63596518&oldid=1857337955"